NEW YORK (GenomeWeb News) – Biocept today went public as shares of its common stock began trading at $10, the low end of an anticipated price range on its initial public offering.

In afternoon trading, the company's shares, which trade under ticker symbol "BIOC" on the Nasdaq, were down 6 percent at $9.39.

The San Diego-based oncology diagnostics firm offered 1.9 million shares of its common stock as part of its IPO, which is expected to bring in $19 million in gross proceeds. The offering is expected to close on Feb. 10.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.